GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $645,000 | -74.2% | 9,506 | -77.9% | 1.27% | -27.7% |
| Q2 2019 | $2,499,000 | +24.6% | 42,966 | +50.1% | 1.76% | +24.8% |
| Q1 2019 | $2,005,000 | +2.7% | 28,619 | -5.6% | 1.41% | -8.4% |
| Q4 2018 | $1,953,000 | -41.8% | 30,319 | -36.6% | 1.54% | -29.9% |
| Q3 2018 | $3,357,000 | -5.5% | 47,803 | -32.2% | 2.20% | -6.8% |
| Q2 2018 | $3,552,000 | +42.7% | 70,470 | -11.5% | 2.36% | +32.6% |
| Q1 2018 | $2,490,000 | +15.7% | 79,591 | +26.5% | 1.78% | -3.7% |
| Q4 2017 | $2,152,000 | +25.5% | 62,926 | +17.8% | 1.85% | +36.1% |
| Q3 2017 | $1,715,000 | +0.4% | 53,439 | +1.9% | 1.36% | -10.1% |
| Q2 2017 | $1,708,000 | -29.4% | 52,459 | -31.7% | 1.51% | -33.9% |
| Q1 2017 | $2,420,000 | +28.4% | 76,851 | +19.8% | 2.28% | +23.1% |
| Q4 2016 | $1,885,000 | +46.5% | 64,147 | +5.5% | 1.86% | -48.2% |
| Q3 2015 | $1,287,000 | -15.8% | 60,828 | +10.7% | 3.58% | +73.4% |
| Q2 2015 | $1,528,000 | +55.4% | 54,966 | +70.9% | 2.07% | +11.2% |
| Q1 2015 | $983,000 | – | 32,167 | – | 1.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
| Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
| Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
| Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
| Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
| Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
| CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
| Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |